Jiwei Zhang

发表

Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin

Shaoming Chi, Sichuan Xu, Wei Xie, 2015, Journal of biomolecular structure & dynamics.

Design and synthesis of chitin synthase inhibitors as potent fungicides

Xinling Yang, Yun Ling, Jun Yang, 2017 .

Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.

P. Zhan, Xinyong Liu, A. Loregian, 2020, European journal of medicinal chemistry.

Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant

P. Zhan, Xinyong Liu, A. Loregian, 2022, Molecules.

Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors.

P. Zhan, Xinyong Liu, L. Menéndez-Arias, 2022, European journal of medicinal chemistry.

Iterative Optimization and Structure-Activity Relationship Studies of Oseltamivir Amino Derivatives as Potent and Selective Neuraminidase Inhibitors via Targeting 150-Cavity.

Dongwei Kang, P. Zhan, Xinyong Liu, 2022, Journal of medicinal chemistry.

Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2

P. Zhan, Lijun Rong, Ruikun Du, 2023, Journal of medical virology.

Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors.

P. Zhan, Xinyong Liu, P. Kar, 2023, European journal of medicinal chemistry.

Sulfonic acid: key drug design elements with potent, broad-ranging pharmacological activities.

P. Zhan, Xinyong Liu, E. D. da Silva-Júnior, 2023, Future medicinal chemistry.

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation

P. Zhan, Xinyong Liu, A. Loregian, 2023, Journal of enzyme inhibition and medicinal chemistry.

Identification of a small-molecule Tim-3 inhibitor to potentiate T cell–mediated antitumor immunotherapy in preclinical mouse models

P. Zhan, Xinyong Liu, Xuetian Yue, 2023, Science Translational Medicine.